RxDoctor Payments Data

Mary Shick

Adult Health · Missoula, MTNPI 1568828226

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $287 of the $319 with a category attached, or 89.9%. 8 manufacturers reported payments, led by Corcept Therapeutics at 34.1% of the total. That places this record below the midpoint for adult health clinicians in MT, where the typical reported total is $768.

$319in general payments, 2019–2025

Across 8 payments — averaging $39.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$109
  • Insulet Corporation$90
  • Novo Nordisk$32
  • Sequel Med Tech, LLC$31
  • Hologic Sales And Service, LLC$17
  • Medtronic$14
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$28790%
  • Education$3210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$319 in reported general payments places this provider in the 35th percentile of 27 adult health providers in Montana.

See all adult health providers in Montana

Medicare billing

Part B allowed, 2024
$75,011
Medicare patients
245
Services billed
918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide147$156,582
JardianceEmpagliflozin98$104,859
TrulicityDulaglutide41$38,600
MounjaroTirzepatide30$31,196
Tresiba Flextouch U-100Insulin Degludec52$30,472
RybelsusSemaglutide14$29,276
FarxigaDapagliflozin Propanediol22$27,336
XareltoRivaroxaban40$25,872
EliquisApixaban20$23,315
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$23,295
CreonLipase/Protease/Amylase12$15,036
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$9,612
Breo ElliptaFluticasone/Vilanterol24$9,097
Humalog Kwikpen U-100Insulin Lispro33$7,341
Lantus SolostarInsulin Glargine,hum.Rec.Anlog74$7,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$32$185,858161 claims
AstraZenecaFarxiga, Symbicort$13$30,96637 claims
AbbVieCreon$14$15,03612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 27 adult health providers in Montana.

Other adult health in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →